Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
Globe Newswire21-10-2024, 11:00
Airshare Continues Growth, Plans to Double Fractional Challenger Fleet with New Agreement Featuring Bombardier’s Challenger 3500 Aircraft 26-07-2023, 17:45